检索结果 - Markku J. Savolainen

Refine Results
  1. 1
    Carbamylation-induced alterations in low-density lipoprotein metabolism

    Carbamylation-induced alterations in low-density lipoprotein metabolism 由 Sohvi Hörkkö, Markku J. Savolainen, Kari Kervinen, Y. Antero Kesäniemi

    出版 1992
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Lack of association between polymorphisms of catalase, copper–zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus

    Lack of association between polymorphisms of catalase, copper–zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in... 由 Olavi Ukkola, P. H. Erkkilä, Markku J. Savolainen, Y. Antero Kesäniemi

    出版 2001
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects

    Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects 由 Seppo Pöykkö, Olavi Ukkola, Heikki Kauma, Markku J. Savolainen, Y. Antero Kesäniemi

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects

    Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects 由 Asko O. Rantala, Heikki Kauma, Mauno Lilja, Markku J. Savolainen, Antti Reunanen, Y. Antero Kesäniemi

    出版 1999
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy

    Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy 由 Tiia Kangas‐Kontio, Satu Vavuli, Sakari Kakko, James Penna, E-R Savolainen, Markku J. Savolainen, Johanna Liinamaa

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life

    High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life 由 Maria E. Rämet, Mika Rämet, Qing Lu, Moriah Nickerson, Markku J. Savolainen, Amy Malzone, Richard H. Karas

    出版 2003
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)

    Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study) 由 Aki Juhani Käräjämäki, Olli-Pekka Pätsi, Markku J. Savolainen, Y. Antero Kesäniemi, Heikki V. Huikuri, Olavi Ukkola

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Persuasive user experiences of a health Behavior Change Support System: A 12-month study for prevention of metabolic syndrome

    Persuasive user experiences of a health Behavior Change Support System: A 12-month study for prevention of metabolic syndrome 由 Pasi Karppinen, Harri Oinas‐Kukkonen, Tuomas Alahäivälä, Terhi Jokelainen, Anna-Maria Keränen, Tuire Salonurmi, Markku J. Savolainen

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Opportunities and challenges of behavior change support systems for enhancing habit formation: A qualitative study

    Opportunities and challenges of behavior change support systems for enhancing habit formation: A qualitative study 由 Pasi Karppinen, Harri Oinas‐Kukkonen, Tuomas Alahäivälä, Terhi Jokelainen, Anna-Maria Teeriniemi, Tuire Salonurmi, Markku J. Savolainen

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease.

    Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. 由 Tatu Juvonen, Markku J. Savolainen, Matti I. Kairaluoma, Lauri H. J. Lajunen, Steve E. Humphries, Y. Antero Kesäniemi

    出版 1995
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

    Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study 由 Johanna Puurunen, Terhi Piltonen, Katri Puukka, Aimo Ruokonen, Markku J. Savolainen, Risto Bloigu, Laure Morin‐Papunen, Juha S. Tapanainen

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohort

    Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohort 由 Jarkko Karvonen, Heikki Kauma, Kari Kervinen, Maire Rantala, Markku J. Ikäheimo, M. Pãivänsalo, Markku J. Savolainen, Y. Antero Kesäniemi

    出版 2002
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    The Apolipoprotein ε4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction

    The Apolipoprotein ε4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction 由 Lars Ulrik Gerdes, Christian Gerdes, Kari Kervinen, Markku J. Savolainen, Ib Christian Klausen, Peter S. Hansen, Y. Antero Kesäniemi, Ole Færgeman

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data

    A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data 由 Aki Vehtari, Ville‐Petteri Mäkinen, Pasi Soininen, Petri Ingman, Sanna Mäkelä, Markku J. Savolainen, Minna L. Hannuksela, Kimmo Kaski, Mika Ala‐Korpela

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma.

    1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. 由 Mika Ala‐Korpela, A. Korhonen, Jeremia Keisala, Sohvi Hörkkö, P Korpi, L. P. Ingman, Jukka Jokisaari, Markku J. Savolainen, Y. Antero Kesäniemi

    出版 1994
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Five-year follow-up of a randomized weight loss trial on a digital health behaviour change support system

    Five-year follow-up of a randomized weight loss trial on a digital health behaviour change support system 由 Eero Turkkila, T. Pekkala, Heta Merikallio, Marko Merikukka, Laura Heikkilä, Janne Hukkanen, Harri Oinas‐Kukkonen, Tuire Salonurmi, Anna-Maria Teeriniemi, Terhi Jokelainen, Markku J. Savolainen

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    A randomized clinical trial of the effectiveness of a Web‐based health behaviour change support system and group lifestyle counselling on body weight loss in overweight and obese subjects: 2‐year outcomes

    A randomized clinical trial of the effectiveness of a Web‐based health behaviour change support system and group lifestyle counselling on body weight loss in overweight and obese s... 由 Anna-Maria Teeriniemi, Tuire Salonurmi, Terhi Jokelainen, Hannu Vähänikkilä, Tuomas Alahäivälä, Pasi Karppinen, Heidi Enwald, Maija‐Leena Huotari, Jaana Laitinen, Harri Oinas‐Kukkonen, Markku J. Savolainen

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

    Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide 由 Arne Astrup, Raffaele Carraro, Nick Finer, A E Harper, Marie Kunešová, MEJ Lean, Leo Niskanen, Maria Rasmussen, A Rissanen, Stephan Rössner, Markku J. Savolainen, L. Van Gaal

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2‐mediated mechanism

    Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2‐mediated mechanism 由 Mikko Karpale, Aki Juhani Käräjämäki, Outi Kummu, Helena Gylling, Tuulia Hyötyläinen, Matej Orešič, Ari Tolonen, Heidi Hautajärvi, Markku J. Savolainen, Mika Ala‐Korpela, Janne Hukkanen, Jukka Hakkola

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Triglyceride‐cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study

    Triglyceride‐cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study 由 Ville‐Petteri Mäkinen, Pasi Soininen, Antti J. Kangas, Carol Forsblom, Nina Tolonen, Lena M. Thorn, Jorma Viikari, Olli T. Raitakari, Markku J. Savolainen, Per‐Henrik Groop, Mika Ala‐Korpela

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: